glp-1 news nov 2025 november Agonists Market Report 2025-2033, By Product, Molecule, and Geo glp-1 news november 2025 ISPOR – GLP-1s: The Swiss Army Knife

Better metabolic labs: fasting glucose drops, A1C normalizes, triglycerides improve, blood pressure stabilizes

Valvular heart disease associated with fenfluramine-phentermine

GLP-1 receptor agonists in obese patients with inflammatory bowel disease: from molecular mechanisms to clinical considerations and practical recommendations for safe and effective use

Adding NAD+ supplementation to a GLP-1 protocol without measuring baseline NAD+ levels is, by the standards of that same engagement, a gap

Being strategic about when you eat can help you manage hunger, maintain stable energy levels, and regulate your blood sugar more effectively throughout the day

The decision to initiate pharmacotherapy requires shared decision-making, discussing realistic expectations, potential adverse effects, cost considerations, and the likely need for indefinite treatment duration